Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACESO-IHD
NCT04776239Phase 2Completed
- Start
- Aug 2021
- Primary completion
- Mar 2025
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of allogeneic bone marrow-derived human mesenchymal stem cells in ischemic heart disease (IHD). Started Aug 2021; status: completed.
02
Drugs
allogeneic bone marrow-derived human mesenchymal stem cells
03
Conditions
ischemic heart disease (IHD)
Beyond the preview
Go deeper on NCT04776239.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04776239.